Genomic medicine has been a strong theme in the news this month, with key developments in the US in particular suggesting that genome sequencing may be moving more quickly towards clinical implementation.
Most prominent in the news are the potential applications of genomics for improved cancer management, including genetically targeted therapeutics.
Recent moves to make regulation in the UK less onerous for medical research aim to facilitate patient involvement easier; sequencing data threatens to overwhelm current IT capacity for research and medicine; and the use of medical biomarkers raises new questions.
The utility of genetic data for risk prediction and disease prevention have been examined this month, and research shows the wider benefits of genetic diagnosis for retinoblastoma.
Poor access to specialist services for dystrophy patients is costing the UK health service, according to a new report; UK screening protocols for haemoglobinopathies have been revised, and opportunities to improve prostate cancer screening are highlighted.
Research has suggested genetic links with suicide and dementia; a prominent stem cell therapeutic trial for spinal repair is called off; and funding for research into genomic factors in wound repair has been announced.